David Del Bourgo

David Del Bourgo has a diverse and extensive work experience in various roles and industries. David is currently the CEO co-founder of WhiteLab Genomics, a company that specializes in developing and operating an AI platform for genomic therapies. Prior to this, they worked as the Head of Sales and Marketing at Genomic Vision from 2014 to 2018. Before that, they served as the VP of Marketing, BD, and Sales at Theraclion from 2009 to 2014. David also worked as the Director of Marketing and Business Development - Medical Imaging at Orbotech from 2006 to 2009. Additionally, they held the position of Manager Strategic Consulting at Advention Business Partners from 2005 to 2006. David started their career at GE Healthcare, where they held various roles such as Global Product Manager and European Program Manager. David also participated in the GE Leadership Program and gained experience in Advanced Applications in Medical Imaging. Overall, David Del Bourgo has a strong background in genomics, marketing, sales, business development, and strategic consulting.

David Del Bourgo has a diverse education history. In 1993, they pursued a Master of Science (M.Sc.) degree in Biomedical Engineering from Université de Technologie de Compiègne (UTC), where they completed their studies in 1996. Afterward, they attended Tel Aviv University and obtained a Master of Science (MS) degree in Biomedical/Medical Engineering, graduating in 1998.

Continuing their academic journey, David pursued higher education at The University of Chicago Booth School of Business starting in 2004. David enrolled in their Master of Business Administration (MBA) program and specialized in General Management, Marketing, and Finance. David successfully completed their MBA studies in 2006.

More recently, in 2022, David participated in an educational program at Y Combinator. While the specific degree or field of study is not mentioned, their involvement underscores their commitment to continue expanding their knowledge and skills.